SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-012724
Filing Date
2014-02-24
Accepted
2014-02-24 16:15:32
Documents
3
Period of Report
2014-02-18
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-6521_18k.htm 8-K 30245
2 EX-2.1 a14-6521_1ex2d1.htm EX-2.1 640654
3 EX-99.1 a14-6521_1ex99d1.htm EX-99.1 151633
  Complete submission text file 0001104659-14-012724.txt   823934
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 14637131
SIC: 2834 Pharmaceutical Preparations